Critical appraisal of the mouse model of myocardial infarction

Experimental Physiology

Volumn 89, Issue 4, 2004, Pages 497-505

  Degabriele, Naomi M ^a   Griesenbach, Uta ^a   Sato, Kaori ^b,c   Post, Mark J ^b,d   Zhu, Jie ^a   Williams, John ^a   Jeffery, Peter K ^a   Geddes, Duncan M ^a   Alton, Eric W F W ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b HARVARD UNIVERSITY   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; HEART FUNCTION; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE PRESSURE; HISTOPATHOLOGY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MORPHOLOGY; MOUSE; NONHUMAN; PHENOTYPE; PRESSURE MEASUREMENT; QUANTITATIVE ANALYSIS; SURVIVAL TIME; SUTURING METHOD;

EID: 3543121131     PISSN: 09580670     EISSN: None     Source Type: Journal    
DOI: 10.1113/expphysiol.2004.027276     Document Type: Article

References (30)

1. 2-adrenergic receptors. Am J Physiol 279, H2456-H2463.
2. Du X-J, Gao X & Ramsey D (1998). Surgical methods of inducing transverse aortic stenosis and myocardial infarction in the mouse. Asia Pacific Heart J 7, 187-192.
3. Gao X-M, Dart AM, Dewar E, Jennings G & Du X-J (2000). Serial echocardiographic assessment of left ventricular dimensions and function after myocardial infarction in mice. Cardiovascular Res 45, 330-338.
4. Giordano FJ, Ping P, McKirnan D, Nozaki S, DeMaria AN, Dillmann WH, Mathieu-Costello O & Hammond K (1996). Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nature Med 2, 534-539.
5. Guo Y, Wu W-J, Qiu Y, Tang X-L, Yang Z & Bolli R (1998). Demonstration of an early and a late phase of ischemic preconditioning in mice. Am J Physiol 275, H1375-H1387.
6. Hariawala MD, Horowitz JR, Esakof D, Sheriff DD, Walter DH, Keyt B, Isner JM & Symes JF (1996). VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J Surg Res 63, 77-82.
7. Laham RJ, Rezaee M, Post M, Novicki D, Sellke FW, Pearlman JD, Simons M & Hung D (2000). Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischaemia. J Pharmacol Exp Therapeutics 292, 795-802.
8. Laham RJ, Sellke FW, Edelman ER, Pearlman JD, Ware A, Brown DL, Gold JP & Simons M (1999). Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 100, 1865-1871.
9. Lopez JJ, Laham RJ, Stamler A, Pearlman JD, Bunting S, Kaplan A, Carrozza JP & Sellke FW (1998). VEGF administration in chronic myocardial ischemia in pigs. Cardiovascular Res 40, 272-281.
10. Losordo DW, Vale PR, Symes JF, Dunnington CH, Esakof DD, Maysky M, Ashare AB, Lathi K & Isner JM (1998). Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98, 2800-2804.
11. Lutgens E, Daemen MJAP, de Muinck ED, Debet J, Leenders P & Smits JFM (1999). Chronic myocardial infarction in the mouse: cardiac structural and functional changes. Cardiovascular Res 41, 586-593.
12. Mack CA, Patel SR, Schwarz EA, Zanzonico P, Hahn RT, Ilercil A, Devereux RB, Goldsmith SJ, Christian TF, Sanborn TA, Kovesdi I, Hackett N, Isom OW, Crystal RG & Rosengart TK (1998). Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J Thoracic Cardiovascular Surg 115, 168-177.
13. Mannion JD, Blood V, Bailey W, Bauer TL, Magno MG, DiMeo F, Epple A & Spinale FG (1996). The effect of basic fibroblast growth factor on the blood flow and morphologic features of a latissimus dorsi cardiomyoplasty. J Thoracic Cardiovascular Surg 111, 19-28.
14. Michael LH, Ballantyne CM, Zachariah JP, Gould KE, Pocius JS, Taffet GE, Hartley CJ, Pham TT, Daniel SL, Funk E & Entman ML (1999). Myocardial infarction and remodeling in mice. Effect of reperfusion. Am J Physiol 277, H660-H668.
15. Michael LH, Entman ML, Hartley CJ, Youker KA, Zhu J, Hall SR, Hawkins HK, Berens K & Ballantyne CM (1995). Myocardial ischemia and reperfusion: a murine model. Am J Physiol 269, H2147-H2154.
16. Papaioannou VE & Fox JG (1993). Efficacy of tribromoethanol anesthesia in mice. Laboratory Anim Sci 43, 189-192.
17. Patel SR, Lee LY, Mack CA, Polce DR, El-Sawy T, Hackett NR, Ilercil A, Jones EC, Hahn RT, Isom OW, Rosengart TK & Crystal RG (1999). Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121. Human Gene Ther 10, 1331-1348.
18. Patten RD, Aronovitz MJ, Deras-Mejia L, Pandian NG, Hanak GG, Smith JJ, Mendelsohn ME & Konstam MA (1998). Ventricular remodeling in a mouse model of myocardial infarction. Am J 274, H1812-H1820.
19. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadoro J, Kloner RA & Braunwald E (1979). Myocardial infarct size and ventricular function in rats. Circulation Res 44, 503-512.
20. Rosengart TK, Lee LY, Patel SR, Kligfield PD, Okin PM, Hackett NR, Isom W & Crystal RG (1999a). Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA. Ann Surg 230, 466-472.
21. Rosengart TK, Lee LY, Patel SR, Sanborn TA, Parikh M, Bergman GW, Hachamovitch R, Szulc M, Kligfield PD, Okin PM, Hahn RT, Devereux RB, Post MR, Hackett NR, Foster T, Grasso TM, Lesser ML, Isom W & Crystal RG (1999b). Phase I assessment of direct intramyocardial administration of an adenovirus vector expression VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 100, 468-474.
22. Sato K, Laham RJ, Pearlman JD, Novicki D, Sellke FW, Simons M & Post MJ (2000). Efficacy of intracoronary versus intravenous FGF-2 in a pig model of chronic myocardial ischemia. Ann Thoracic Surg 70, 2113-2118.
23. Sato K, Wu T, Laham RJ, Johnson RB, Douglas P, Li J, Sellke FW, Bunting S, Simons M, & Post MJ (2001). Efficacy of intracoronary or intravenous VEGF in a pig model of chronic myocardial ischemia. J Am College Cardiol 37, 616-623.
24. Schaper W, De Brabander M & Lewi P (1970). DNA synthesis and mitoses in coronary collateral vessels of the dog. Circulation Res 28, 671-679.
25. Scherrer-Crosbie M, Steudel W, Ullrich R, Hunziker PR, Liel-Cohen N, Newell J, Zaroff J, Zapol WM & Picard MH (1999). Echocardiographic determination of risk area size in a murine model of myocardial ischemia. Am J Physiol 277, H986-H992.
26. Shou M, Thirumurti V, Sharmini Rajanayagam MA, Lazarous DF, Hodge E, Stiber JA, Pettiford M, Elliot E, Shah SM & Unger EF (1997). Effect of basic fibroblast growth factor on myocardial angiogenesis in dogs with mature collateral vessels. J Am College Cardiogl 29, 1102-1106.
27. Symes JF, Losordo DW, Vale PR, Lathi KG, Esakof DD, Mayskiy M & Isner JM (1999). Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thoracic Surg 68, 830-837.
28. Tio RA, Tkebuchava T, Scheuermann TH, Lebherz C, Magner M, Kearny M, Esakof DD, Isner JM & Symes JF (1999). Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium. Human Gene Ther 10, 2953-2960.
29. Vale PR, Losordo DW, Milliken CE, McDonald MC, Gravelin LM, Curry CM, Esakof DD, Maysky M, Symes JF & Isner JM (2001). Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation 103, 2138-2143.
30. Ware JA & Simons M (1999). Angiogenesis and Cardiovascular Disease. Oxford University Press, New York.